chrisvoncsefalvay/vaers-outcomes huggingface dataset:
She got swelling like her first time; This is a spontaneous report received from a contactable reporter(s) (Physician) from medical information team. The reporter is the patient.  A 62 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 17Dec2020 (Lot number: EK5730) at the age of 62 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: SWELLING (non-serious), outcome "unknown", described as "She got swelling like her first time". Additional Information: Patient received the first dose of the Pfizer covid vaccine in Dec and 2nd dose in Jan. Afterwards she was diagnosed with breast cancer. She went through breast surgery, radiation. She was on a shorter course in Jul that ended in Aug then she went in for her booster dose of the Pfizer covid vaccine on 21Aug2021. She got swelling like her first time and it lingered and got lymphedema. After the 2nd dose of the Pfizer covid vaccine she had lots of fatigue and lots of swelling in the arm. Patient's second injection was in the first week of Jan2021. She got the booster but in between all of that time, she got the Breast Cancer Diagnosis, have to have a mass removed surgery (Further clarification unknown) and then they did what is it called a sentinel node biopsy (Not clarified) and this is on the left side. She had no Lymphedema post-surgery at all and then got the injection on that left side, and then this is on the 21Aug2021 and her arm been swelled up with pretty significant Lymphedema. It's just starting to go away. Patient had no other vaccine within 4 weeks of vaccination.   Follow-up attempts are completed. No further information is expected.
G40.901 STATUS EPILEPTICUS 2/28/2022 ASTHMA, UNSPECIFIED J96.00 ACUTE RESPIRATORY FAILURE 11/29/2021 ASTHMA, UNSPECIFIED J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 2/28/2022 ASTHMA, UNSPECIFIED G40.901 STATUS EPILEPTICUS 2/28/2022 ASTHMA, UNSPECIFIED J96.00 ACUTE RESPIRATORY FAILURE 11/29/2021 ASTHMA, UNSPECIFIED J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 2/28/2022 ASTHMA, UNSPECIFIED
Patient received the vaccines (Typhoid, Hep A, Yellow Fever, & PPD).  After receiving the vaccines the patient became light-headed and clammy but stayed alert and oriented.
Systemic: Chills-Severe, Systemic: chills led to hyperventilation-Severe; symptoms lasted 0 days
The area S/P HIB vaccine became cellulitic with 1/2 cm ^2 of redness and 1 cm^2 of induration: treated with Keflex.
No adverse symptoms at the time. patient was monitored for 30 minutes after event. patient wanted the Johnson and Johnson vaccine but was accidentally the 1st dose of the 2 series pfizer vaccines. She had never received any of the FDA covid 19 vaccines before this incident
guillian barre syndrome; This case was reported by a consumer via interactive digital media and described the occurrence of guillain barre syndrome in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced guillain barre syndrome (serious criteria GSK medically significant). On an unknown date, the outcome of the guillain barre syndrome was unknown.   The reporter considered the guillain barre syndrome to be related to Shingrix.     Additional Information: GSK Receipt Date: 10-DEC-2022 Reporter's Comment: This case was reported by a patient via interactive digital media. The patient reported that one Shingrix vaccine gave him/her Guillain Barre syndrome. Additional Supportive Information: Follow-up would not possible as no contact details were available.
Fatigue, sore throat, light coughing, chest heaviness, swollen lower lip, itchy eyes, muscle aches in leg joints.
Systemic: Abdominal Pain-Medium, Systemic: Nausea-Medium, Systemic: Vomiting-Medium, Systemic: Dizziness-Medium
a 54 year old reported the same (Drug-induced Lupus/Lupus)/after their 2nd dose of the Moderna vaccine(Lupus); This spontaneous case was reported by a nurse and describes the occurrence of LUPUS-LIKE SYNDROME (a 54 year old reported the same (Drug-induced Lupus/Lupus)/after their 2nd dose of the Moderna vaccine(Lupus)) in a 54-year-old male patient who received mRNA-1273 (Spikevax) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced LUPUS-LIKE SYNDROME (a 54 year old reported the same (Drug-induced Lupus/Lupus)/after their 2nd dose of the Moderna vaccine(Lupus)) (seriousness criterion medically significant). At the time of the report, LUPUS-LIKE SYNDROME (a 54 year old reported the same (Drug-induced Lupus/Lupus)/after their 2nd dose of the Moderna vaccine(Lupus)) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication were reported. No treatment medication were reported.  Company Comment: This is a spontaneous case concerning a 54-year-old male patient with no reported medical history, who experienced the unexpected, serious (medically significant) event of Lupus-like syndrome, after receiving the second dose of mRNA-1273 vaccine. Dates of vaccination, onset date of the event, clinical course, diagnostic tests and treatment details were not provided in the case. The outcome of the event was unknown at the time of the report. The benefit-risk relationship of mRNA-1273 is not affected by this report.   This case was linked to MOD-2022-598087, MOD-2022-598068.; Sender's Comments: This is a spontaneous case concerning a 54-year-old male patient with no reported medical history, who experienced the unexpected, serious (medically significant) event of Lupus-like syndrome, after receiving the second dose of mRNA-1273 vaccine. Dates of vaccination, onset date of the event, clinical course, diagnostic tests and treatment details were not provided in the case. The outcome of the event was unknown at the time of the report. The benefit-risk relationship of mRNA-1273 is not affected by this report. US-MODERNATX, INC.-MOD-2022-598089:same reporter
I received the vaccination. I might have been in the store for another 5 minutes, and I left and I was walking home. I would say like 10-15 minutes after the vaccine as I was walking home, I started to experience tightness in my chest. I walked home very slowly and I probably took my albuterol then. I went home. I can?t remember if I had a headache because I had a headache for the first two. But I did not go to work the next day because I was very dizzy and nauseous. The chest tightness subsided and it was gone the next day.
11/30/22  I started having a sore throat, a cough and a lot of congestion. This continued for several days. I took a home COVID test on the morning of 11/30/22 and it was positive.  I called the doctor, but I was unable to talk to her until 12/2/22. I was prescribed Amoxicillin and cough medicine with codeine. I was unable to get the cough medicine because I was unable to find it.  After a couple of days, I developed diarrhea, and the doctor told me to stop taking the Amoxicillin. The diarrhea stopped after that. I just have lingering symptoms like a little bit of a cough and a little bit of drainage. I have mainly recovered.
Pt had a mild fever of 100.4, Pt treated with TYLENOL.
3 very swollen and painful lymph nodes left armpit, 1 swollen lymph node left side of neck.  Unable to sleep due to pain and pain not completely relieved with Tylenol or Advil.   She has been encouraged to follow up with family physician if they do not decrease by 2/5/2021 or pain doesn't lessen.
Patient stated she noticed lump at injection site following vaccination, over the course of a few days after, various bruises appeared on the left side of her body and she noticed some numbness/tingling in her fingers.
The report was first received from a practice manager on 07-SEP-2018, and it was recognized as non-valid because report did not obtain any patient identify. Follow-up information has been received from the practice manager on 18-SEP-2018. This spontaneous report refers to a patient of unknown age and gender. Information of concurrent condition, medical history and concomitant therapy was not provided. On 13-MAR-2018, the patient was vaccinated with an improperly stored dose of GARDASIL 9 (strength and route were unknown) (lot# N020352 and expiration date 10-APR-2020) for prophylaxis. No adverse event was reported. The excursion temperature on 08-NOV-2017, 16-NOV-2017, 23-JAN-2018, 06-JUN-2018, 03-JUL-2018 and 14-AUG-2018 was 47 degree Celsius for maximize 15 hours. The excursion temperature on 07-DEC-2017 was 50 degree Celsius for maximize 8.75 hours. The call was not because of data logger. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1810USA001951: US-009507513-1810USA001952: US-009507513-1810USA001953: US-009507513-1810USA001954: US-009507513-1810USA001955: US-009507513-1810USA001957: US-009507513-1810USA001958: US-009507513-1810USA001959: US-009507513-1809USA003709.
Nurse gave patient 0.1 ml intra dermal injection of flu instead of 0.1 ml of PPD intra dermal. PPD vaccine 11/17/06 red, slightly warm to touch at side of influenza injection site.
Fetus was normal in 12 week ultrasound on 08/12/21. Went in for anatomy scan on 10/8/21 and fetus had developed hydrops fetalis. Due date unknown  At appointment on 11/10/22 fetus had fetal demise and heart stopped. Delivered stillborn. Birth weight 1 pound 10 ounces.
Pain in arm immediately upon injection. Extreme dizziness, light-headedness, and a warm flush came over me within 2-3 minutes. Sat down on a chair, put my head between my knees. Wasn't helping so I sat down on the floor cross-legged and put my head to the ground to try to keep myself from fainting. A medic noticed I wasn't doing well and took me to a tent on the other side of the large room to lie down. She asked if I wanted a wheelchair and I declined. I barely made it to the tent to lie down before I would have fainted. Lying down was significantly better than sitting down. After staying prone for about 20 minutes, I was doing better so I left. Immediately after walking outside and feeling cool fresh air I was much much better. Dull headache approximately 19hrs after shot that lasted half a day.  48hrs post shot had tingling and numbness in injection arm that lasted about a day. Injection arm soreness for 3 days total.
Headaches the next day and tiredness, short of breath, had to go to the hospital unable to breath when laying down quizzing couldn't catch breath ER dx him with Cardiomyopathy. Had knot holes on his thyroid.
Adult female patient received an Enerix-b peds; Adult received Engerix B pediatic (0.5ml); This case was reported by a nurse via call center representative and described the occurrence of adult use of a child product in a 22-year-old female patient who received HBV (Engerix B pediatric) (batch number 333m4, expiry date 7th April 2024) for prophylaxis.   Co-suspect products included hepatitis B vaccine pre-filled syringe device (Engerix B Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 12th August 2022, the patient received Engerix B pediatric and Engerix B Pre-Filled Syringe Device. On 12th August 2022, unknown after receiving Engerix B pediatric and Engerix B Pre-Filled Syringe Device, the patient experienced adult use of a child product and underdose. On an unknown date, the outcome of the adult use of a child product and underdose were unknown.     This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 12-AUG-2022 Reporter's Comments: The nurse reported that an adult female patient received an Engerix B paediatrics. The patient had no adverse event was reported.  The reporter consented to follow up. Additional supportive information: The adult patient received a child dose of Engerix B pediatric, which led to adult use of a child product and underdose.
Patient used an incorrect date of birth to register for the vaccine appointment and therefor was vaccinated four days prior to his 16th birthday.
This RN received phone call from spouse of individual who received a flu vaccine at their place of employment on 9-27-2018. Spouse reports husband received flu vaccine and almost immediately had issues with pain and has continued to progress. Reports left arm is unusable without unbearable pain. Reports went to Walk-In Clinic on 10-24-2018 as "could not stand the pain anymore." Reports XRay completed and informed to follow-up with Primary Care Physician. Has appointment on November 8, 2018, Physician.
This spontaneous report was received from a healthcare worker refers to a patient of unknown gender and age. Information regarding the patient's medical history, concurrent condition, drug reactions/allergies and concomitant medications were not provided. On 12-SEP-2016, the patient was vaccinated with an improperly stored dose of PROQUAD (lot # M029599, expiry date: 10-DEC-2017). A data logger was involved. Healthcare worker reported that the vaccine underwent temperature excursion at 19.5F for 23 hours. They stated that the vaccine was previously exposed at 8.5F for 4 hours and 15 minutes. No adverse effect was reported. This is one of the four reports received from the same reporter. Additional information has been requested.
NAUSEA AND VOMITING; DIARRHEA (10/22/20@12:04) Narrative:
I had fatigue for about 24 hours after receiving the vaccine. I started not feeling well on 01/09/2023 with a sore throat, body aches, lots of serious congestion and no fever. I really thought I just had a bad cold. I went to a clinic to be tested and I tested positive for COVID-19 on 01/13/2023. They recommended guaifenesin to help with the congestion. I tolerated the medication well. I still have some congestion and I stay fatigued.
Pt reports that she had the vaccine 2 dose 5/10/2021  and she start having symptoms of general weakness at 6 am ,burning sensation at 1pm bilateral legs ,most painful in both feet.She called the PCP and they recommend her go to Urgent Care .Pt was sent to ER and US bilateral was performance ,no blood cot.Pt is scheduled with PCP for 5-20-2021. Prescribed Percocet and Benadryl
Pt rec. ZOSTAVAX shot 6-3-13. Several (2-3) days later called pharmacy and was complaining of a swollen area on the vaccinated arm, in the elbow area with a slightly bumpy feel to it.
pt recv vax 3JUN96 & back to clinic 4JUN96 pt would not walk, there was swelling @ inj site on lt leg;there was no redness;pt did not have fever or any sz sx;10JUN96 parents stats pt is running around like crazy
This spontaneous report was received from a medical assistant and refers to an unspecified number of patients of unknown age and gender. On unknown dates, the patients were vaccinated with an improperly stored dose of ROTATEQ lot # N000172 and expiration date: 10-JUN-2018. No adverse effects were reported. The digital data logger was involved in recording the temperature excursion. This is one of four reports received from the same reporter.; Sender's Comments: US-009507513-1708USA010646: US-009507513-1708USA008059: US-009507513-1708USA010656:
dose was given after expiration date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (dose was given after expiration date) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Oct-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (dose was given after expiration date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (dose was given after expiration date) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication information was provided. No treatment information was provided.  No adverse event was reported. The vial had not undergone any temperature excursion issue. The vial was initially placed in the refrigerator on 18-Oct-2021. Many doses were administered from expired lots due to confusion with the expiration date printed in the label.
patient complains of limited range of motion in left arm following immunization on 9/19/19.
This case was reported by a nurse via call center representative and described the occurrence of fever in a 4-year-old male patient who received FLULAVAL QUADRIVALENT (batch number TL72B, expiry date 26th June 2019) for prophylaxis. On 9th October 2018, the patient received FLULAVAL QUADRIVALENT (intramuscular). In October 2018, several hours after receiving FLULAVAL QUADRIVALENT, the patient experienced fever. On an unknown date, the outcome of the fever was unknown. It was unknown if the reporter considered the fever to be related to FLULAVAL QUADRIVALENT. Additional details were provided as follows: It was reported that, the patient received FLULAVAL and experienced a fever of 102.4.
Several days after immunization patient experienced sudden onset of sever muscle/joint pain. Over the counter pain medications helped some. Pain lasted several hours from 11am to late afternoon.
Mom states she took child to see doctor at  Med. Ctr. after vaccination.Child had white bumps in mouth, looks like pimples on outside bur pus filled on inside of mouth.Might have fever, fussy and won't eat. Mom told nurse that Doctor said child has a virus not a reaction to vaccine given.
Rash- 20-30 papules on trunk and groin - No vesicles - very itchy
Information has been received from a physician concerning a 5 year old Caucasian patient who in approximately 1997 was vaccinated with the first dose of MMRII. Immediately following the vaccination, the patient developed a fever which lasted for seven days. The patient sought medical attention. It was reported that the patient recovered. FOLLOW-UP information noted that the physician did not have any details about the episode since the physician did not have the patient at the time. It was also noted that the patient did receive a second dose of MMRII and that there were no adverse events reported. No further information is available.
I received Spiknax 3030536 Friday. Sat- nausea, lethargic, no appetite, spent the day in bed. Sun- nausea in the am and part of the afternoon ate a little dinner. Mon-C, ate normal dinner. Tues - nausea in the am had pedialyte pop but ended up throwing it up, yogurt for late lunch, lite dinner.  Wed- nausea in the am yogurt for lunch, lite dinner. Thurs.-toast for breakfast ended up throwing it up. yogurt  for lunch. I also had the flu shot which i think might of also added to the sickness.
Patient admitted to hospital with DKA 1 week after getting 2nd dose of Moderna vaccine.  Subsequent lab workup showed evidence of type 1 diabetes, positive antibodies, low C-peptide
03/10/2021 I started feeling fatigued, hard time breathing, got to point I checked my oxygen, almost felt like I had covid. o appetite. Next day It started with pain, body aches, severe, after pain, fever came 102.1, I was doing advil but fever would not break. It was really bad for the first 3 days. Got to point I had to go get covid test at PA in Wharton, had no test, no smell, lasted about a month. Visited Doctor  first week in April because Doctor was out due to loss of kids in house fire so it took a while to get in. He had done some blood work earlier in March, my numbers were bad- WBC, and he put me on a antibiotic, Zpack, just in case I did have covid, but I didn't feel any of these symptoms until after I got J&J shot.
burning between her belly button and breasts; sharp pain in her belly; arm felt like someone punched her; Severe Stomach Pain; stomach pain was unbelievable; So Much Diarrhea; Peeing out of her butt; This is a spontaneous report from a contactable nurse reporting for herself.    A 72-years-old female patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration on 13Apr2021 11:30 (Batch/Lot Number: ER8731) as single dose for covid-19 immunisation  .  The patient medical history and concomitant medications were not reported.  The patient experienced severe stomach pain; stomach pain was unbelievable on 13Apr2021 with outcome of recovering , so much diarrhea; peeing out of her butt on 13Apr2021 with outcome of recovered on 17Apr2021 , sharp pain in her belly  on 14Apr2021 with outcome of recovering , burning between her belly button and breasts  on 15Apr2021 with outcome of recovered on 17Apr2021 , arm felt like someone punched her on 13Apr2021 with outcome of recovered on 15Apr2021.  The patient underwent lab tests and procedures which included blood test: unknown   on 26Apr2021. All the reported events were considered Important Medical Events.  Causality: Caller stated yes, it is related to the vaccine. Stated she doesnt get diarrhea. Stated she eats healthy and doesnt ever get diarrhea, well maybe once in a blue moon. Caller states she thinks it is totally related to the vaccine.  Follow up information has been requested. Lot number was already provided.; Sender's Comments: A causal association between BNT162B2 and the reported events cannot be excluded based on a compatible temporal relation. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RAs, Ethics Committees, and Investigators, as appropriate.
covid; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (covid) in a female patient of an unknown age who received mRNA-1273 (Spikevax) for COVID-19 prophylaxis.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Spikevax) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced COVID-19 (covid). At the time of the report, COVID-19 (covid) outcome was unknown. Not Provided          Concomitant medications were not reported. Treatment medications were not reported.   This case was linked to US-MODERNATX, INC.-MOD-2022-690376, US-MODERNATX, INC.-MOD-2022-690379 (E2B Linked Report). This case was linked to MOD-2022-690385 (Patient Link).; Sender's Comments:  US-MODERNATX, INC.-MOD-2022-690376:Reporter's Case US-MODERNATX, INC.-MOD-2022-690379:Other people case